|
A recent Economic Development Report highlights PARI and several other Virginia based companies that expanded their export business with the support of the Commonwealth of Virginia. Featured on page 10, PARI has successfully expanded market penetration and operations into Latin America. The VEDP program received the 2008 "E Star" award from the President of the United States and recognizes superior performance in increasing or promoting exports and it is the most prestigious export award available.
To view report, click here: |
|
PARI presented a study comparing the PARI LC Sprint, PARI LC Plus, and Respironics Sidestream Plus reusable nebulizers to determine performance and efficiency using Budesonide. The study looks closely at Respirable Drug Delivery Rate (RDDR) as an objective measure for evaluating nebulizer performance. Key findings:
» RDDR is highest with LC® Sprint and 46% higher compared to Sidestream Plus(p<0.002)
» LC® PLUS RDDR is 39% higher compared to Sidestream Plus (p<0.002)
» Treatment time was shortest for the LC Sprint at 4.9 min (p<0.0001)
Previous studies have shown, a higher RDDR indicates more drug delivery to the lungs per minute. Therefore, it is important for clinicians to consider RDDR when prescribing specific nebulizers to ensure patients receive clinically effective doses.
|
Please mark your calendars:
PARI will be closed on the following days:
November 27th 2008
November 28th 2008
December 24th 2008
December 25th 2008
January 1st 2009
Also view:
|
